Literature DB >> 17089319

Can intrapleural C-reactive protein predict VATS pleurodesis failure?

F Leo1, N Vénissac, D Pop, A Rosenthal-Allieri, J Mouroux.   

Abstract

BACKGROUND: Intrapleural inflammatory reaction after surgery for spontaneous pneumothorax is a key indicator whether an effective pleurodesis has been achieved. In this study, we tested the hypothesis that intrapleural C-reactive protein (CRP) might precisely quantify the postoperative pleural inflammation, offering potentially useful information for patient management.
METHODS: The study population consisted of 75 consecutive patients who underwent video-assisted thoracoscopic pleurectomy or pleural abrasion for spontaneous pneumothorax between April 2003 and August 2004. We assessed CRP levels in pleural and blood samples taken daily in the first 4 postoperative days.
RESULTS: Intrapleural CRP profile was significantly lower in patients who underwent pleural abrasion, in younger patients (< 25 years) and in patients who were not drained before surgery. Patients with pleurodesis failure had a lower CRP peak with a delayed peak. Receiving operating characteristics (ROC) analysis showed that the cutoff value of intrapleural CRP for pleurodesis failure was 25 mg/l on the second postoperative day (sensitivity 87.5 %, specificity 66.6 %, positive predictive value 24.1, negative predictive value 97.7 %).
CONCLUSIONS: Pleural CRP levels of less than 25 mg/l on the second postoperative day indicate only a moderate pleural inflammation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17089319     DOI: 10.1055/s-2006-924249

Source DB:  PubMed          Journal:  Thorac Cardiovasc Surg        ISSN: 0171-6425            Impact factor:   1.827


  1 in total

1.  Efficacy of medical thoracoscopic talc pleurodesis in malignant pleural effusion caused by different types of tumors and different pathological classifications of lung cancer.

Authors:  Juan Chen; Zhu Li; Ning Xu; Xin Zhang; Yu Wang; Dianjie Lin
Journal:  Int J Clin Exp Med       Date:  2015-10-15
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.